NEW YORK (360Dx) – Mologic and Fraunhofer today announced a collaboration to develop a rapid, point-of-care test for the diagnosis of bacterial urinary tract infections and any associated antibiotic susceptibility.

The test being developed would be used in a primary care setting. Fraunhofer was awarded £900,000 ($1.3 million) by SBRI Healthcare, a National Health Service England Initiative, in support of the project, the companies said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.